Top 4 Mid-Cap Stocks In The Medical Laboratories & Research Industry With The Highest EPS Estimates (LH, DGX, CVD, ALR)

Below are the top mid-cap medical laboratories & research stocks on the NYSE and the NASDAQ in terms of earnings estimate for the next quarter. The earnings estimate for Laboratory Corp of America Holdings LH for the next quarter ending March, 2011 is $1.37 per share. LH's trailing-twelve-month ROE is 26.48%. Quest Diagnostics Incorporated DGX is expected to earn $0.97 per share over the next quarter ending March, 2011. DGX's trailing-twelve-month operating margin is 18.25%. Covance Inc CVD is likely to earn $0.65 per share in the next quarter ending March, 2011. CVD's trailing-twelve-month operating margin is 9.96%. Alere Inc ALR may earn $0.65 per share in the next quarter ending March, 2011. ALR's PEG ratio is 1.44. Trading Ideas.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: MarketsTrading IdeasHealth CareHealth Care ServicesHighest EPS EstimatesLife Sciences Tools & ServicesMedical Laboratories & Research IndustryMid-Cap
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!